Ifosfamide: should the honeymoon be over?
BA Kamen, E Frenkel, and OM Colvin
JCO Feb 1 1995: 307–309. [PDF]
CNS leukemia: problem of diagnosis, treatment, and outcome
PG Steinherz
JCO Feb 1 1995: 310–313. [PDF]
	Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer
	B Chevallier, P Fumoleau, P Kerbrat, V Dieras, H Roche, I Krakowski, N Azli, M Bayssas, MA Lentz, and M Van Glabbeke
	JCO Feb 1 1995: 314–322. [Abstract] [PDF]
	Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile
	KK Fields, GJ Elfenbein, HM Lazarus, BW Cooper, JB Perkins, RJ Creger, OF Ballester, JH Hiemenz, WE Janssen, and PE Zorsky
	JCO Feb 1 1995: 323–332. [Abstract] [PDF]
	An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia
	RC Ribeiro, GK Rivera, M Hudson, RK Mulhern, ML Hancock, L Kun, H Mahmoud, JT Sandlund, WM Crist, and CH Pui
	JCO Feb 1 1995: 333–338. [Abstract] [PDF]
	Levels of L-asparagine in CSF after intramuscular administration of asparaginase from Erwinia in children with acute lymphoblastic leukemia
	SP Dibenedetto, A Di Cataldo, R Ragusa, C Meli, and L Lo Nigro
	JCO Feb 1 1995: 339–344. [Abstract] [PDF]
	Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology
	K Schmiegelow, H Schroder, G Gustafsson, J Kristinsson, A Glomstein, T Salmi, and L Wranne
	JCO Feb 1 1995: 345–351. [Abstract] [PDF]
	Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association
	C Uderzo, MG Valsecchi, A Bacigalupo, G Meloni, C Messina, P Polchi, G Di Girolamo, G Dini, R Miniero, and F Locatelli
	JCO Feb 1 1995: 352–358. [Abstract] [PDF]
	Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Munster Group
	A Reiter, M Schrappe, R Parwaresch, G Henze, S Muller-Weihrich, S Sauter, KW Sykora, WD Ludwig, H Gadner, and H Riehm
	JCO Feb 1 1995: 359–372. [Abstract] [PDF]
	CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus- related systemic lymphomas
	U Tirelli, E Vaccher, V Zagonel, R Talamini, D Bernardi, M Tavio, A Gloghini, MC Merola, S Monfardini, and A Carbone
	JCO Feb 1 1995: 373–380. [Abstract] [PDF]
	Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas
	WH Wilson, BA Chabner, G Bryant, S Bates, A Fojo, J Regis, ES Jaffe, SM Steinberg, BR Goldspiel, and BD Cheson
	JCO Feb 1 1995: 381–386. [Abstract] [PDF]
	Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity
	M Hill, S Milan, D Cunningham, J Mansi, I Smith, D Catovsky, M Gore, G Zulian, P Selby, and A Horwich
	JCO Feb 1 1995: 387–395. [Abstract] [PDF]
	Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation
	R Colwill, M Crump, F Couture, R Danish, AK Stewart, DM Sutton, JG Scott, SB Sutcliffe, JM Brandwein, and A Keating
	JCO Feb 1 1995: 396–402. [Abstract] [PDF]
	Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group
	R Munker, D Hasenclever, O Brosteanu, E Hiller, and V Diehl
	JCO Feb 1 1995: 403–409. [Abstract] [PDF]
	Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin
	Y Merrouche, S Negrier, C Bain, V Combaret, A Mercatello, B Coronel, JF Moskovtchenko, P Tolstoshev, R Moen, and T Philip
	JCO Feb 1 1995: 410–418. [Abstract] [PDF]
	Rapid in vitro assay for predicting response to fluorouracil in patients with metastatic breast cancer
	RM Elledge, GM Clark, J Hon, M Thant, R Belt, YP Maguire, J Brown, P Bartels, and DD Von Hoff
	JCO Feb 1 1995: 419–423. [Abstract] [PDF]
	High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer
	IE Smith, G Walsh, A Jones, J Prendiville, S Johnston, B Gusterson, F Ramage, H Robertshaw, N Sacks, and S Ebbs
	JCO Feb 1 1995: 424–429. [Abstract] [PDF]
	Influence of prior and subsequent pregnancy on breast cancer prognosis
	E von Schoultz, H Johansson, N Wilking, and LE Rutqvist
	JCO Feb 1 1995: 430–434. [Abstract] [PDF]
	Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement
	O Ung, AO Langlands, B Barraclough, and J Boyages
	JCO Feb 1 1995: 435–443. [Abstract] [PDF]
	Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association
	MH Tattersall, V Lorvidhaya, V Vootiprux, A Cheirsilpa, F Wong, T Azhar, HP Lee, SB Kang, A Manalo, and MS Yen
	JCO Feb 1 1995: 444–451. [Abstract] [PDF]
	Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer
	B Jeremic, Y Shibamoto, L Acimovic, and L Djuric
	JCO Feb 1 1995: 452–458. [Abstract] [PDF]
	Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer
	MJ Zelefsky, SA Leibel, KE Wallner, WF Whitmore, Jr, and Z Fuks
	JCO Feb 1 1995: 459–463. [Abstract] [PDF]
	Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis
	WR Lee, GE Hanks, TE Schultheiss, BW Corn, and MA Hunt
	JCO Feb 1 1995: 464–469. [Abstract] [PDF]
	Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial
	Sr Loehrer PJ, D Johnson, P Elson, LH Einhorn, and D Trump
	JCO Feb 1 1995: 470–476. [Abstract] [PDF]
	Tumor angiogenesis as a predictor of recurrence in gastric carcinoma
	K Maeda, YS Chung, S Takatsuka, Y Ogawa, T Sawada, Y Yamashita, N Onoda, Y Kato, A Nitta, and Y Arimoto
	JCO Feb 1 1995: 477–481. [Abstract] [PDF]
	Phase I trial of escalating doses of interleukin-1 beta in combination with a fixed dose of interleukin-2
	PL Triozzi, JA Kim, EW Martin, DC Young, T Benzies, and PM Villasmil
	JCO Feb 1 1995: 482–489. [Abstract] [PDF]
	Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities
	DR Gandara, WA Nahhas, MD Adelson, SM Lichtman, ES Podczaski, S Yanovich, HD Homesley, P Braly, PS Ritch, and SR Weisberg
	JCO Feb 1 1995: 490–496. [Abstract] [PDF]
	Multiinstitutional home-therapy trial of recombinant human interleukin- 2 and interferon alfa-2 in progressive metastatic renal cell carcinoma
	J Atzpodien, E Lopez Hanninen, H Kirchner, H Bodenstein, M Pfreundschuh, U Rebmann, B Metzner, HJ Illiger, G Jakse, and T Niesel
	JCO Feb 1 1995: 497–501. [Abstract] [PDF]
	The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation
	GP Browman, MN Levine, EA Mohide, RS Hayward, KI Pritchard, A Gafni, and A Laupacis
	JCO Feb 1 1995: 502–512. [Abstract] [PDF]
	Use of tamoxifen for breast cancer: twenty-eight years later
	IA Jaiyesimi, AU Buzdar, DA Decker, and GN Hortobagyi
	JCO Feb 1 1995: 513–529. [Abstract] [PDF]
CA-125 in primary mediastinal B-cell lymphoma with sclerosis
C Ravoet, JL Dargent, F Le Moine, and W Feremans
JCO Feb 1 1995: 530–531. [PDF]
Paclitaxel-induced "recall" soft tissue injury
GA Basler, S Desmond-Hellmann, and AP Florczyk
JCO Feb 1 1995: 531a. [PDF]
Myocardial ischemia and infarction associated with vinorelbine
A Bergeron, O Raffy, and JM Vannetzel
JCO Feb 1 1995: 531b–532. [PDF]
Leiomyosarcoma of the urinary bladder after cyclophosphamide
J Pedersen-Bjergaard, V Jonsson, M Pedersen, and K Hou-Jensen
JCO Feb 1 1995: 532–533. [PDF]
Second malignancies after testicular cancer
LB Travis, RE Curtis, and BF Hankey
JCO Feb 1 1995: 533–534. [PDF]
Pneumonitis related to treatment with paclitaxel
HL Goldberg and SB Vannice
JCO Feb 1 1995: 534–535. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.